Evidence map›Paper›PMID 33192612›Full record

ReviewFrontiers in physiology2020

Physiological Ca

Ang Li, Jianxun Yi, Xuejun Li, Jingsong Zhou

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Old and new biomarkers for volumetric muscle loss.Current opinion in pharmacology · 2021
    Review
  14. Article
  15. CaNeuroscience letters · 2021
    Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ang LiDepartment of Kinesiology, College of Nursing and Health Innovation, The University of Texas at Arlington, Arlington, TX, United States.
Jianxun YiDepartment of Kinesiology, College of Nursing and Health Innovation, The University of Texas at Arlington, Arlington, TX, United States.
Xuejun LiDepartment of Kinesiology, College of Nursing and Health Innovation, The University of Texas at Arlington, Arlington, TX, United States.
Jingsong ZhouDepartment of Kinesiology, College of Nursing and Health Innovation, The University of Texas at Arlington, Arlington, TX, United States.
The University of Texas at Arlington · US

Funding

Preserving Mitochondrial Function for Alleviating ALS ProgressionR01NS105621 · NINDS · UNIVERSITY OF TEXAS ARLINGTON · PI BROTTO, MARCO, ZHOU, JINGSONG · 2019 to 2023
$2.9M
Ca signaling cross-talk from SR to mitochondria in heart muscleR01HL138570 · NHLBI · OHIO STATE UNIVERSITY · PI LIN, PEI-HUI, ZHOU, JINGSONG · 2018 to 2021
$2.6M
Ca Signaling in Progression of Amyotrophic Lateral Sclerosis in Skeletal MuscleR01AR057404 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI ZHOU, JINGSONG · 2010 to 2014
$1.6M
NHLBI NIH HHS R01 HL138570NIAMS NIH HHS R01 AR057404NINDS NIH HHS R01 NS105621
6 · The paper itself

Abstract

Mitochondria are both the primary provider of ATP and the pivotal regulator of cell death, which are essential for physiological muscle activities. Ca

Indexed as

electric field stimulationmitochondrial Ca2+ homeostasismitochondrial ROSmitoflashskeletal muscletransitory mPTP opening

Identifiers

PMID33192612
PMCPMC7642813
OpenAlexW3094084205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.